Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ypsomed Holding AGXSWX:YPSN +2.40%92 5-Year Yield-on-Cost % is 10.00 as of Jul. 17, 2026, which is 122% above its 10-year median of 4.50. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF396.62 (Fairly Valued). The stock has 3 warning signs investors should review. Among 325 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 89.23% on this metric.
Ypsomed Holding AG's yield on cost for the quarter that ended in Mar. 2026 was 10.00.
The historical rank and industry rank for Ypsomed Holding AG's 5-Year Yield-on-Cost % or its related term are showing as below:
XSWX:YPSN'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.92 Med: 4.5 Max: 10.5
Current: 10
During the past 13 years, Ypsomed Holding AG's highest Yield on Cost was 10.50. The lowest was 0.92. And the median was 4.50.
XSWX:YPSN's 5-Year Yield-on-Cost % is ranked better than 89.23% of 325
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs XSWX:YPSN: 10.00
Ypsomed Holding AG (XSWX:YPSN) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Ypsomed Holding AG 5-Year Yield-on-Cost % Related Terms
XSWX:YPSN vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's 5-Year Yield-on-Cost % falls into.
Ypsomed Holding AG 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Ypsomed Holding AG (XSWX:YPSN) has a 5-Year Yield-on-Cost % of 10.00 as of Jul. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ypsomed Holding AG and its competitors. This is 122% above median its historical median of 4.50. Over the past decade, Ypsomed Holding AG's 5-Year Yield-on-Cost % has ranged from 0.92 to 10.50. According to the industry distribution chart, Ypsomed Holding AG ranks #35 out of 325 companies in the Medical Devices & Instruments industry, placing it in the top 10.8%.
Is Ypsomed Holding AG's 5-Year Yield-on-Cost % too high?
Ypsomed Holding AG's current 5-Year Yield-on-Cost % of 10.00 is 122% above median its 10-year median of 4.50. Over the past 10 years, this metric has ranged from a low of 0.92 to a high of 10.50. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.31. Ypsomed Holding AG's value of 10.00 is 332.9% above this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #35 out of 325 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #35 out of 325 companies for 5-Year Yield-on-Cost %. This places Ypsomed Holding AG in the top 11% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.31. Ypsomed Holding AG's value of 10.00 is 332.9% above this benchmark. Historically, Ypsomed Holding AG's own 5-Year Yield-on-Cost % has ranged from 0.92 to 10.50 over the past decade. While the company's 10-year median is 4.50 vs. the industry median of 2.31, Ypsomed Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.31, based on 325 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current 5-Year Yield-on-Cost % of 10.00 is 332.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current 5-Year Yield-on-Cost % is 10.00, which is 122% above median its own 10-year median of 4.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF396.62, compared to a current price of CHF375.40 — trading 5.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 10.00, which is 122% above median its 10-year median of 4.50 and 332.9% above the Medical Devices & Instruments industry median of 2.31. Ypsomed Holding AG's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current 5-Year Yield-on-Cost % is 10.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF375.40 is trading 5.4% below its estimated GF Value™ of CHF396.62.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for XSWX:YPSN:
5-Year Yield-on-Cost %: 10.00 (122% above median its 10-year median of 4.50)
GF Value™: CHF396.62 vs. price of CHF375.40 (5.4% below fair value)
Industry Position: 332.9% above the Medical Devices & Instruments median (#35 of 325)
No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score
Get the complete analysis for XSWX:YPSN
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:YPSN has been successfully added to your 
